A Decade in Drug Policy and Research: Evaluating Trends from 2010 to 2020 and Presenting Major Policy Developments

Shafi, Saahir; Mallinson, Daniel J.

doi:10.18278/psy.12.1.4

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, federal research support flows disproportionately to addiction research instead of efficacy research (O'Grady, 2020). The academic literature has been following drug liberalization in increasing its output on efficacy and greater attention to opioids and cannabis (Shafi & Mallinson, 2022), but federal money and research restrictions have agenda-setting effects for science. State-legal research programs are now generating research, but the United States is decades behind in evaluating the medicinal potential of cannabis.…”

Section: Limits Of Federal Research Rulesmentioning

confidence: 99%

Veterans and Medical Cannabis: A Perfect Federalism Storm

Mallinson,

Puello

2023

Public Administration Quarterly

Self Cite

View full text Add to dashboard Cite

Lingering federal prohibition of cannabis sales and possession creates myriad problems for state-legal users. This is particularly the case for military veterans. The Department of Veterans Affairs (VA) has issued confusing guidance at times regarding the ability of veterans to access state-legal medical cannabis and how VA doctors can advise their patients. This paper will examine the ways that veterans can fall through the cracks in accessing state-legal medical cannabis for the treatment of service-related chronic illnesses like post-traumatic stress disorder (PTSD), chronic pain, and traumatic brain injury (TBI). It begins with a review of the research specific to cannabis as a treatment for PTSD, pain, and TBI. It then reviews the history and present scope of states that include these as approved conditions under their medical cannabis programs. The article then turns to discussing the evolving guidance provided by the VA to patients and doctors and federal restrictions on efficacy research. The article concludes by discussing the administrative burdens veterans face accessing state-legal medical cannabis and how they will be compounded as states begin legalizing medical uses for other controlled substances like psylocibin mushrooms and MDMA (ecstasy).

show abstract

Section: Limits Of Federal Research Rulesmentioning

confidence: 99%

Veterans and Medical Cannabis: A Perfect Federalism Storm

Mallinson,

Puello

2023

Public Administration Quarterly

Self Cite

View full text Add to dashboard Cite

show abstract

“…The defiant adoption and implementation of drug liberalization laws offers rich ground for testing and building public policy and public administration theory. Alas, research within both policy and administration journals remains scant (Shafi andMallinson 2022, Kavousi et al 2022). Researchers have used cannabis policy to test policy diffusion theory Mallinson 2018, Johns 2015) and theories of federalism (Christensen andWise 2009, Mallinson and, which are natural fits, but also collaborative governance (Raab andMilward 2003, Waardenburg et al 2020), performance-based management (Simeone, Carnevale, and Millar 2005), and institutional design (Meier and Smith 1994).…”

Section: Paq Vol 47 Issuementioning

confidence: 99%

Introduction to the Special Issue on Cannabis Policy in the United States: Challenges and Opportunities for Public Administration and Policy

Mallinson¹,

Hannah²

2023

Public Administration Quarterly

Self Cite

View full text Add to dashboard Cite

The state-legal cannabis industry has grown rapidly over the last few years. The decline of cannabis prohibition enforcement by the federal government and the adoption of medical and adult-use programs in the states have pushed the logic of prohibition to the brink. Even so, the legacy of federal and state prohibition looms over nearly every move that those in industry and policy administration make. Retail sales of medical and recreational cannabis were expected to reach $33 billion in 2022 and is projected to reach over $50 billion by 2026 (Editors 2022). Seemingly impervious to the COVID-19 pandemic, the cannabis market in the United States grew by 51% in 2022 (Fortune Business Insights 2021). In fact, the pandemic helped to accelerate cannabis access as many states largely deemed the product to be an essential service, ushering in expanded online ordering, pickup, and delivery of product. While only 23 percent of the U.S. population lives in a state without comprehensive medical or recreational marijuana, many of those live close enough to a bordering state-legal program. With cannabis remaining under federal prohibition, however, the states, the industry, and consumers face a variety of ongoing challenges.Cannabis liberalization is also part of a serious reconsideration of the fifty-year War on Drugs that has been building in the United States. Mass incarceration's devastating effects on communities of color have been widely recognized (Alexander 2010), but drug policy reform has been slow and tenuous. The states have driven the liberalization of American drug policy since California adopted the first comprehensive medical cannabis program in 1996. To date, 38 states have comprehensive medical cannabis programs and 19 have adult-use recreational. Liberalization is now in the process of expanding with consideration and adoption of broad decriminalization measures and medicinal psylocibin mushroom programs. For all this growth and change, however, cannabis, among other substances, remains federally prohibited under the Controlled Substances Act of 1970. The federal government has been fickle in its enforcement of the CSA, which has led to confusion and uncertainty in the nascent, but substantial, industry Cunningham 2020, Adler 2020).

show abstract

A Decade in Drug Policy and Research: Evaluating Trends from 2010 to 2020 and Presenting Major Policy Developments

Cited by 2 publications

References 0 publications

Veterans and Medical Cannabis: A Perfect Federalism Storm

Veterans and Medical Cannabis: A Perfect Federalism Storm

Introduction to the Special Issue on Cannabis Policy in the United States: Challenges and Opportunities for Public Administration and Policy

Contact Info

Product

Resources

About